Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Prepaid Assets: 2011-2024

Historic Prepaid Assets for Adma Biologics (ADMA) over the last 11 years, with Dec 2024 value amounting to $8.0 million.

  • Adma Biologics' Prepaid Assets fell 27.40% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year decrease of 27.40%. This contributed to the annual value of $8.0 million for FY2024, which is 50.52% up from last year.
  • Per Adma Biologics' latest filing, its Prepaid Assets stood at $8.0 million for FY2024, which was up 50.52% from $5.3 million recorded in FY2023.
  • In the past 5 years, Adma Biologics' Prepaid Assets ranged from a high of $8.0 million in FY2024 and a low of $3.0 million during FY2020.
  • For the 3-year period, Adma Biologics' Prepaid Assets averaged around $6.2 million, with its median value being $5.3 million (2023).
  • Data for Adma Biologics' Prepaid Assets shows a peak YoY skyrocketed of 50.52% (in 2024) over the last 5 years.
  • Over the past 5 years, Adma Biologics' Prepaid Assets (Yearly) stood at $3.0 million in 2020, then skyrocketed by 42.44% to $4.3 million in 2021, then rose by 17.42% to $5.1 million in 2022, then increased by 4.69% to $5.3 million in 2023, then skyrocketed by 50.52% to $8.0 million in 2024.